COVID-19 Hemostasis and Malignancy: the Bergamo Experience
The COVID-19 pandemic took one of its biggest tolls on Italy, and especially in the northern area, in Lombardy. In this...
LATEST ARTICLES
The Art of Managing Cancer-Associated Thrombosis: Caravaggio and Beyond
Venous thromboembolism (VTE) is a frequent complication and the second leading cause of death in cancer patients....
Fundamental research in oncology and thrombosis – the Frontline experience
What is the physician perception and common practice in treatment of venous thromboembolism (VTE) in cancer patients?...
Toward the replacement of low-molecular-weight heparins with the novel direct oral anticoagulants for the treatment of cancer-associated thrombosis
Value and limitations of low-molecular-weight heparins Following the demonstration that vitamin K antagonists (VKA) are...
COVID-19 and Management of Thrombotic Disease
The coronavirus disease 2019 (COVID-19) pandemic has posed a series of new questions in management of patients....
Impact of COVID-19 on healthcare workers and health systems
After the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak, the adoption of specific personal...
MOST READ
SOCIAL
Concomitant #DVT in pts w cancer & incidental PE seems to be unrelated to survival in contrast to DVT in pts w symptomatic acute PE:
Prognostic Significance of Incidental Deep Vein Thrombosis in Patients with Cancer Presenting with Incidental Pulmonary Embolism
In symptomatic acute pulmonary embolism (PE), the presence of deep vein thrombosis (DVT) is a risk factor for 30- and 90-day mortality. In patients wi...
doi.org